Article
Interpretable machine learning-driven biomarker identification and validation for Alzheimer’s disease
28 Dec 2024
Abstract excerpt
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by limited effective treatments, underscoring the critical need for early detection and diagnosis to improve intervention outcomes. This study integrates various bioinformatics methodologies with interpretable machine learning to identify reliable biomarkers for AD diagnosis and treatment. By leveraging differentially expressed genes (DEGs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
